M K Proteins accepts Laxmi Mandal resignation as independent director
M K Proteins Limited announced the acceptance of Ms. Laxmi Mandal's resignation as Independent Director effective August 12, 2026. Citing other business obligations, Ms. Mandal confirmed no material reasons for her exit. The filing was made under SEBI LODR regulations.

*this image is generated using AI for illustrative purposes only.
M K Proteins Limited has accepted the resignation of Ms. Laxmi Mandal as an Independent Director on its board, effective August 12, 2026.
Ms. Mandal, whose Director Identification Number is 05287716, informed the company that she is stepping down due to other business obligations. In her communication to the Board of Directors dated August 12, 2026, she confirmed that there are no material reasons for her resignation other than those stated in her letter.
The company disclosed this development in a filing with the Bombay Stock Exchange and the National Stock Exchange of India on August 13, 2026. The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para A of Part A of Schedule III.
Board Composition Update
Ms. Mandal’s departure reduces the number of independent directors on the board. The company confirmed that she does not hold directorships in any other listed entities.
Neha Aggarwal, Company Secretary and Compliance Officer of M K Proteins Limited, signed the intimation filed with the stock exchanges. The company thanked Ms. Mandal for her cooperation and guidance during her tenure.
Historical Stock Returns for MK Proteins
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | -0.71% | -9.13% | -20.68% | -38.26% | +50.36% |
How will M K Proteins Limited ensure compliance with SEBI's mandatory independent director requirements following Ms. Mandal's departure?
What is the company's timeline for appointing a successor to maintain board stability and governance standards?
Could the reduction in independent directors impact investor confidence or the company's stock performance in the short term?


































